Page results
-
Our arrhythmia service is designed to treat patients with all types of heart rhythm problems.
-
The UCLH cardio-oncology service provides a centralised, high-quality, consultant-based outpatient clinical service.
-
Waldenström’s macroglobulinaemia is a rare form of lymphoma (a type of bone marrow cancer), treated at UCLH.
-
The UCLH dermatology department diagnoses and treats all forms of skin cancer including low- and high- risk basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and malignant melanoma.
-
UCLH has a comprehensive lung cancer service and sees patients from across the UK.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
UCLH is a designated specialist centre for the treatment of head and neck cancer for people in north and east London and west Essex.
-
UCLH is an established tertiary referral colorectal unit. We offer comprehensive surgical and medical treatment for anal, colon and rectal cancers.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
File results
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2022/0663 - Migraine treatment
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0342 - Self-administration of medication policies